{"id":"W2809853196","doi":"10.1017/cjn.2018.129","title":"P.027 Efficacy of a fourth alemtuzumab course in RRMS patients from CARE-MS II who experienced disease activity after three prior courses","year":2018,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Medicine; Alemtuzumab; Expanded Disability Status Scale; Multiple sclerosis; Internal medicine; Relapsing remitting; Physical therapy; Surgery; Disease; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000596287,0.0002810594,0.0005437951,0.0001767537,0.0003033272,0.0005122684,0.0002669147,0.0003341155,0.002889636],"category_scores_gemma":[0.001284647,0.0000928099,0.0005651623,0.0001542295,0.0002125527,0.000251695,0.0001978383,0.0007014611,0.0004312663],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007102455,"about_ca_system_score_gemma":0.0007985899,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002249146,"about_ca_topic_score_gemma":0.003253703,"domain_scores_codex":[0.9997218,0.0000788936,0.0000236635,0.000056374,0.00004801403,0.00007114044],"domain_scores_gemma":[0.9993535,0.0001217997,0.0001695873,0.00003281793,0.00007919873,0.0002430302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2085643,0.008840359,0.5236004,0.0004236338,0.001379598,0.0006260328,0.0002937367,0.001438365,0.01549716,0.0001679429,0.008390133,0.2307784],"study_design_scores_gemma":[0.02867031,0.1520063,0.8043352,0.0001136895,0.001071576,0.0009350688,0.0001464716,0.003210651,0.003954727,0.0001499589,0.005374588,0.00003140433],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9979705,0.000609161,0.00003873625,0.0001238658,0.00002270662,0.00006029674,0.0001452168,0.00001229204,0.001017175],"genre_scores_gemma":[0.9987285,0.00009729095,0.0001394691,0.0001321158,0.00003792835,0.00004789542,0.0003710474,0.000002795401,0.0004429227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002889636,"threshold_uncertainty_score":0.0096668,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1346075318253849,"score_gpt":0.3669310335281076,"score_spread":0.2323235017027227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}